Novartis Takes Aim At Cross-Appeal In Zometa Suit

Law360, New York (October 1, 2013, 3:42 PM EDT) -- Novartis Pharmaceuticals Corp. on Monday fought a cross appeal by plaintiffs who had won a $250,000 jury verdict in March over a bone disease allegedly caused by the Swiss drug giant’s cancer-related bone damage drug Zometa but are seeking punitive damages that the jury declined to award them.

The plaintiffs, Florida resident J. Hunter Chiles and his wife Dianna Chiles, have argued argued it was wrong to apply New Jersey’s “idiosyncratic” law restricting such punitive damages to their suit in Florida, according to their brief filed...
To view the full article, register now.